{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:22:33Z","timestamp":1787502153199,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jsbmb.2010.12.006","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T04:29:08Z","timestamp":1292646548000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells"],"prefix":"10.1016","volume":"126","author":[{"given":"Ya","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsbmb.2010.12.006_bib0005","first-page":"341","article-title":"Epidemiology of endometrial cancer. Best practice & research","volume":"15","author":"Purdie","year":"2001","journal-title":"Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.jsbmb.2010.12.006_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers","volume":"70","author":"Benedet","year":"2000","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.jsbmb.2010.12.006_bib0015","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(02)02813-4","article-title":"Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients","volume":"53","author":"Pitson","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.jsbmb.2010.12.006_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00006250-198003000-00019","article-title":"Clinical correlates of estrogen and progesterone-binding proteins in human endometrial adenocarcinoma","volume":"55","author":"Creasman","year":"1980","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.jsbmb.2010.12.006_bib0025","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9378(88)90075-0","article-title":"Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium","volume":"158","author":"Ehrlich","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.jsbmb.2010.12.006_bib0030","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose\u2013response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"47","key":"10.1016\/j.jsbmb.2010.12.006_bib0035","doi-asserted-by":"crossref","first-page":"31308","DOI":"10.1074\/jbc.273.47.31308","article-title":"Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways","volume":"273","author":"Lange","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2010.12.006_bib0040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1210\/endo-113-6-2195","article-title":"In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation","volume":"113","author":"Horwitz","year":"1983","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.jsbmb.2010.12.006_bib0045","first-page":"4576","article-title":"Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium","volume":"61","author":"Arnett-Mansfield","year":"2001","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.jsbmb.2010.12.006_bib0050","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2010.12.006_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0303-7207(99)00092-1","article-title":"Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium","volume":"153","author":"Roy","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.jsbmb.2010.12.006_bib0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/endo.142.3.7991","article-title":"Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor","volume":"142","author":"Navarro","year":"2001","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2010.12.006_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jsbmb.2010.12.006_bib0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/me.2002-0318","volume":"17","author":"Cui","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"2 (Pt 2)","key":"10.1016\/j.jsbmb.2010.12.006_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0b013e3181719b92","article-title":"Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives","volume":"112","author":"Shen","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2010.12.006_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"9","key":"10.1016\/j.jsbmb.2010.12.006_bib0085","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","article-title":"Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.jsbmb.2010.12.006_bib0090","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/emboj\/16.12.3693","article-title":"Rapamycin suppresses 5\u2019TOP mRNA translation through inhibition of p70s6k","volume":"16","author":"Jefferies","year":"1997","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.jsbmb.2010.12.006_bib0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000080286","article-title":"Association between components of the insulin-like growth factor system and endometrial cancer risk","volume":"67","author":"Augustin","year":"2004","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.jsbmb.2010.12.006_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3816\/CBC.2003.n.018","article-title":"Mammalian target of rapamycin: a new molecular target for breast cancer","volume":"4","author":"Mita","year":"2003","journal-title":"Clin. Breast Cancer"},{"issue":"23","key":"10.1016\/j.jsbmb.2010.12.006_bib0105","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate reulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.jsbmb.2010.12.006_bib0110","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.jsbmb.2010.12.006_bib0115","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1073\/pnas.191379498","article-title":"Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP\/RAFT\/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo","volume":"98","author":"Mills","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.jsbmb.2010.12.006_bib0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jsbmb.2010.12.006_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","article-title":"Targeting AMPK: a new therapeutic opportunity in breast cancer","volume":"67","author":"Hadad","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.jsbmb.2010.12.006_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC\u2013mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.jsbmb.2010.12.006_bib0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell. Biol."},{"issue":"5930","key":"10.1016\/j.jsbmb.2010.12.006_bib0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jsbmb.2010.12.006_bib0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.jsbmb.2010.12.006_bib0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jsbmb.2010.12.006_bib0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2010.12.006_bib0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol. Oncol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076010003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076010003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:37:58Z","timestamp":1760744278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076010003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":32,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0960076010003808"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2010.12.006","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2010.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}